Job/Unit: O20736
/KAP1
Date: 26-07-12 15:48:49
Pages: 23
α-Oxygenation of Carbonyl Compounds
ferrocene followed by 496 mg (87%) of 4c and 21 mg (4%) of dimer
dimer 5f[14] was repurified after TEMPO sublimation (hexane/
5c as pale-yellow oils. R = 0.5 (hexane/EtOAc, 10:1). IR (film): ν
EtOAc, 40:1). Colorless oil. IR (film): ν = 2977, 2960, 2938, 2921,
˜
˜
f
= 2964, 2935, 2874, 1748, 1467, 1376, 1362, 1261, 1245, 1181, 1133,
2872, 1736, 1467, 1377, 1191, 1143, 1134, 1032, 790 cm–1. 1H NMR
1031 cm–1. 1H NMR (400 MHz): δ = 0.85 (t, J = 7.3 Hz, 3 H,
(200 MHz): δ = 0.84 (d, J = 6.4 Hz, 3 H, CHCH3), 0.85 (d, J =
CH2CH2CH3), 0.96 (s, 3 H, NCCH3), 1.04 (s, 3 H, NCCH3), 1.05 6.5 Hz, 3 H, CHCH3), 0.96 (s, 3 H, NCCH3), 1.00–1.57 [m, 7 H,
(s, 3 H, NCCH3), 1.11 (s, 3 H, NCCH3), 1.14–1.29 (m, 2 H,
CH2CH2CH3), 1.21 (t, J = 7.1 Hz, 3 H, OCH2CH3), 1.31–1.57 (m,
NCCH2CH2CH2CN, (H3C)2CH], 1.02 (s, 3 H, NCCH3), 1.04 (s, 3
H, NCCH3), 1.12 (s, 3 H, NCCH3), 1.21 (t, J = 7.1 Hz, 3 H,
6 H, NCCH2CH2CH2CN), 1.73 (m, 2 H, CHCH2), 4.09 (q, J = OCH2CH3), 1.66 (AAЈBX, J = 12.9, 10.9, 9.7, 4.6, 4.2 Hz, 2 H,
7.1 Hz, 2 H, OCH2), 4.14 (dd, J = 7.4, 6.8 Hz, 1 H, CHON) ppm.
CH2CHON), 4.09 (q, J = 7.1 Hz, 2 H, OCH2), 4.16 (dd, J = 10.9,
13C NMR (100 MHz): δ = 14.0 (q, CH2CH2CH3), 14.2 (q,
4.6 Hz, 1 H, CHON) ppm. 13C NMR (50 MHz): δ = 14.1 (q,
OCH2CH3), 17.1 (t, NCCH2CH2CH2CN), 17.9 (t, CH2CH2CH3), OCH2CH3), 17.1 (t, NCCH2CH2CH2CN), 19.9 (q, NCCH3), 20.2
20.0 (q, NCCH3), 20.2 (q, NCCH3), 33.0 (q, NCCH3), 33.5 (q, (q, NCCH3), 21.6 (q, CHCH3), 23.8 (q, CHCH3), 24.5 [d,
NCCH3), 34.2 (t, CH2CH2CH3), 40.2 (t, NCCH2CH2CH2CN), CH(CH3)2], 33.0 (q, NCCH3), 33.5 (q, NCCH3), 40.1 (t,
40.3 (t, NCCH2CH2CH2CN), 59.3 (s, NCCH3), 60.1 (t, CH2O),
85.5 (d, CHON), 173.6 (s, CO2) ppm. MS (+CI): m/z (%) = 286
(100) [M + H]+, 164 (12), 142 (22) [TMPH2]+, 126 (13), 116 (12).
C16H31NO3 (269.43): calcd. C 67.33, H 10.95, N 4.91; found C
67.24, H 11.06, N 5.06.
NCCH2CH2CH2CN), 40.2 (t, NCCH2CH2CH2CN), 41.1 (t,
CH2CHON), 59.1 (s, NCCH3), 60.1 (s, NCCH3), 60.3 (t, OCH2),
84.8 (d, CHON), 173.7 (s, CO2) ppm. MS (EI): m/z (%) = 299 (2)
[M]+, 284 (3), 256 (2), 241 (4), 156 (100) [TEMPO]+, 140 (18), 123
(15), 97 (7), 83 (9), 69 (10). C17H33NO3 (299.45): calcd. C 68.18, H
11.08, N 4.67; found C 68.12, H 11.14, N 4.41.
Prenyl 2-(2,2,6,6-Tetramethylpiperidin-1-yloxy)propionate (4d):
Flash chromatography (hexane/EtOAc, 80:1, gradient to 10:1) gave
ferrocene followed by 451 mg (76%) of 4d as a pale-yellow oil. Rf
Methyl 2-Cyclopropyl-2-(2,2,6,6-tetramethylpiperidin-1-yloxy)acet-
ate (4h): Isolation by flash chromatography (hexane/EtOAc, 50:1,
from the end of ferrocene elution 20:1); yield 304 mg (56%) as a
= 0.7 (hexane/EtOAc, 10:1). IR (film): ν = 2974, 2932, 1747, 1449,
˜
1376, 1361, 1260, 1179, 1129, 1075, 1029, 946, 790, 722, 682 cm–1.
colorless oil. R = 0.75 (hexane/EtOAc, 5:1). IR (film): ν = 2931,
˜
f
1H NMR (400 MHz): δ = 0.98 (s, 3 H, NCCH3), 1.06 (s, 6 H,
1741, 1457, 1362, 1263, 1195, 1151, 1134, 1044, 1024, 991, 975,
789 cm–1. 1H NMR (400 MHz):
δ = 0.32–0.46 (m, 1 H,
NCCH3), 1.12 (s,
3 H, NCCH3), 1.22–1.30 (m, 1 H,
CH2CH2CH), 0.46–0.60 (m, 2 H, CH2CH2CH), 0.65–0.80 (m, 1 H,
CH2CH2CH), 1.03 (s, 3 H, NCCH3), 1.10 (s, 3 H, NCCH3), 1.14
(s, 3 H, NCCH3), 1.10–1.20 (m, 1 H, CHCHON), 1.24–1.33 (m, 4
NCCH2CH2CH2CN), 1.34 (d, J = 6.9 Hz, 3 H, CH3CHON), 1.35–
1.54 (m, 5 H, NCCH2CH2CH2CN), 1.65 (s, 3 H, cis-CH3C=CH),
1.70 (s, 3 H, trans-CH3C=CH), 4.26 (q, J = 6.8 Hz, 1 H, CHON),
H, NCCH3, NCCH2CH2CH2CN), 1.37–1.60 (m,
5
H,
4.54 (d,
J
=
7.2 Hz,
2
H, =CHCH2O), 5.31 (m,
1 H,
=CHCH2O) ppm. 13C NMR (101 MHz):
δ
=
17.0 (t,
NCCH2CH2CH2CN), 3.73 (s, 3 H, OCH3), 3.82 (d, J = 9.0 Hz, 1
H, CHON) ppm. 13C NMR (101 MHz): δ = 1.4 (t, CH2CH2CH),
6.9 (t, CH2CH2CH), 13.9 (d, CH2CH2CH), 17.4 (t,
NCCH2CH2CH2CN), 20.3 (q, NCCH3), 20.5 (q, NCCH3), 33.2 (q,
NCCH3), 34.1 (q, NCCH3), 40.5 (t, NCCH2CH2CH2CN), 51.4 (q,
OCH3), 59.9 (s, NCCH3), 60.6 (s, NCCH3), 89.0 (d, CHON), 172.9
(s, CO2) ppm. MS (+ESI): m/z (%) = 292 (100) [M + Na]+, 180
(70) [TEMPOH + Na]+. HRMS: calcd. for C15H27NO3Na+
292.1883; found 292.1883.
NCCH2CH2CH2CN), 17.9 (q, cis-CH3C=CH), 18.1 (q,
CH3CHON), 19.9 (q, NCCH3), 20.1 (q, NCCH3), 25.6 (q, trans-
CH3C=CH), 32.9 (q, NCCH3), 33.5 (q, NCCH3), 40.0 (t,
NCCH2CH2CH2CN), 40.2 (t, NCCH2CH2CH2CN), 59.3 (s,
NCCH3), 59.8 (s, NCCH3), 61.1 (t, =CHCH2O), 81.7 (d, CHON),
118.3 (d, CH3C=CH), 139.0 (s, CH3C=CH), 174.0 (s, CO2) ppm.
MS (+CI): m/z (%) = 298 (100) [M + H]+, 156 (19) [TEMPO]+.
C17H31NO3 (297.42): calcd. C 68.65, H 10.51, N 4.71; found C
68.52, H 10.52, N 4.47.
Methyl anti/syn-3-Methyl-2-(2,2,6,6-tetramethylpiperidin-1-yloxy)-
valerate (4i): Isolation by flash chromatography (hexane/EtOAc,
60:1, from the beginning of TEMPO elution 20:1). For yields and
2-(2,2,6,6-Tetramethylpiperidin-1-yloxy)butyrolactone (4e): Isola-
tion by flash chromatography (hexane/EtOAc, 50:1, from the begin-
ning of TEMPO elution 20:1); yield 362 mg (75%) as a colorless
ratios, see Table 2. Colorless oil. IR (film): ν = 2968, 2935, 2877,
˜
1752, 1739, 1465, 1376, 1362, 1260, 1195, 1135, 1052 cm–1. MS
(+CI): m/z (%) = 286 (100) [M + H]+, 285 (3) [M]+, 270 (3), 156
(36) [TEMPO]+, 142 (3), 123 (2). C16H31NO3 (285.42): calcd. C
67.33, H 10.95, N 4.91; found C 67.59, H 11.07, N 4.74. syn-4i: 1H
NMR (400 MHz): δ = 0.89 (t, J = 6.9 Hz, 3 H, CHCH2CH3), 0.90
(d, J = 6.6 Hz, 3 H, CHCH3), 0.99 (s, 3 H, NCCH3), 1.01 (m, 1
H, CHCH2CH3), 1.07 (s, 3 H, NCCH3), 1.11 (s, 3 H, NCCH3),
1.16 (s, 3 H, NCCH3), 1.20–1.55 (m, 6 H, NCCH2CH2CH2CN),
1.62 (m, 1 H, CHCH2CH3), 2.00 (m, 1 H, CHCH2CH3), 3.64 (s,
3 H, OCH3), 4.14 (d, J = 6.0 Hz, 1 H, CHON) ppm. 13C NMR
(100 MHz): δ = 11.9 (q, CHCH2CH3), 15.5 (q, CHCH3), 17.1 (t,
NCCH2CH2CH2CN), 20.3 (br. q, NCCH3), 23.8 (t, CHCH2CH3),
33.0 (q, NCCH3), 33.9 (q, NCCH3), 37.4 (d, CHCHON), 40.4 (t,
NCCH2CH2CH2CN), 50.8 (q, OCH3), 59.7 (s, NCCH3), 60.2 (s,
oil. R = 0.3 (hexane/EtOAc, 5:1). M.p. 21–22 °C. IR (film): ν =
˜
f
2932, 1786, 1472, 1375, 1261, 1217, 1159, 1113, 1022, 995, 951,
711 cm–1. 1H NMR (400 MHz): δ = 1.10 (s, 3 H, NCCH3), 1.16
(s, 3 H, NCCH3), 1.23 (s, 3 H, NCCH3), 1.32 (s, 4 H, NCCH3,
NCCH2CH2CH2CN), 1.38–1.66 (m, 5 H, NCCH2CH2CH2CN),
2.29 (m, 1 H, CH2CHON), 2.65 (m, 1 H, CH2CHON), 4.05 (ddd,
J = 5.7, 9.2, 10.8 Hz, 1 H, OCH2), 4.32 (td, J = 1.7, 8.9 Hz, 1 H,
OCH2), 4.70 (dd, J = 8.0, 10.9 Hz, 1 H, CHON) ppm. 13C NMR
(101 MHz): δ = 17.2 (t, NCCH2CH2CH2CN), 20.3 (q, NCCH3),
20.5 (q, NCCH3), 31.8 (t, CH2CHON), 32.6 (q, NCCH3), 34.4 (q,
NCCH3), 40.4 (t, NCCH2CH2CH2CN), 59.7 (s, NCCH3), 61.3 (s,
NCCH3), 64.2 (t, OCH2), 80.5 (d, CHON), 174.4 (s, CO2) ppm.
MS (+ESI): m/z (%) = 264 (20) [M + Na]+, 242 (100) [M + H]+.
+
HRMS: calcd. for C13H24NO3 242.1749; found 242.1751; calcd.
1
NCCH3), 88.7 (d, CHON), 172.7 (s, CO2) ppm. anti-4i: H NMR
for C13H23NO3Na+ 264.1570, found 264.1570. C13H23NO3
(241.33): calcd. C 64.70, H 9.61, N 5.80; found C 64.35, H 10.02,
N 5.88.
(400 MHz): δ = 0.87 (t, J = 6.8 Hz, 3 H, CHCH2CH3), 0.92 (d, J
= 6.7 Hz, 3 H, CHCH3), 0.99 (s, 3 H, NCCH3), 1.03 (m, 1 H,
CHCH2CH3), 1.07 (s, 3 H, NCCH3), 1.11 (s, 3 H, NCCH3), 1.16
(s, 3 H, NCCH3), 1.20–1.55 (m, 6 H, NCCH2CH2CH2CN), 1.35
(m, 1 H, CHCH2CH3), 2.04 (m, 1 H, CHCH2CH3), 3.64 (s, 3 H,
OCH3), 4.22 (d, J = 6.0 Hz, 1 H, CHON) ppm. 13C NMR
Ethyl 2-(2,2,6,6-Tetramethylpiperidin-1-yloxy)isocaproate (4f): Iso-
lation by flash column chromatography (hexane/EtOAc, 60:1, from
the beginning of TEMPO elution 20:1). For yields, see Table 2. The
Eur. J. Org. Chem. 0000, 0–0
© 0000 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
11